Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials

The majority of the epigenomic reports in hepatocellular carcinoma have focused on identifying novel differentially methylated drivers or passengers of the oncogenic process. Few reports have considered the technologies in place for clinical translation of newly identified biomarkers. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Michailidi, Christina, Soudry, Ethan, Brait, Mariana, Maldonado, Leonel, Jaffe, Andrew, Ili-Gangas, Carmen, Brebi-Mieville, Priscilla, Perez, Jimena, Kim, Myoung Sook, Zhong, Xiaoli, Yang, Quiang, Valle, Blanca, Meltzer, Stephen J., Torbenson, Michael, Esteller, Manel, Sidransky, David, Guerrero-Preston, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009191/
https://www.ncbi.nlm.nih.gov/pubmed/24829571
http://dx.doi.org/10.1155/2014/597164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009191/
https://www.ncbi.nlm.nih.gov/pubmed/24829571
http://dx.doi.org/10.1155/2014/597164

Ejemplares similares